On December 19, 2022, CytoDyn Inc. and Scott A. Kelly M.D., the Company's Chief Medical Officer, agreed that Dr. Kelly will resign from his role at the Company, effective immediately.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 USD | -2.10% | -6.73% | -28.21% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-28.21% | 142M | |
-2.57% | 103B | |
+1.67% | 95.28B | |
+1.46% | 22.15B | |
-15.54% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.72% | 16.05B | |
+5.35% | 13.68B | |
+34.43% | 12.17B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. Announces Resignation of Scott A. Kelly, Chief Medical Officer